Natural compounds as modulators of cell cycle arrest: application for anticancer chemotherapies
N Bailon-Moscoso, G Cevallos-Solorzano… - Current …, 2017 - ingentaconnect.com
Natural compounds from various plants, microorganisms and marine species play an
important role in the discovery novel components that can be successfully used in numerous …
important role in the discovery novel components that can be successfully used in numerous …
[HTML][HTML] A phase I study of rhizoxin (NSC 332598) by 72-hour continuous intravenous infusion in patients with advanced solid tumors
AW Tolcher, C Aylesworth, J Rizzo, E Izbicka… - Annals of oncology, 2000 - Elsevier
Background Rhizoxin (NSC 332598) is a novel macrolide antitumor antibiotic that inhibits
microtubule assembly and also depolymerizes preformed microtubules. In preclinical …
microtubule assembly and also depolymerizes preformed microtubules. In preclinical …
[PDF][PDF] Preclinical and clinical perspective on fungal metabolites and their analogs as anticancer agents–from bench to bedside
S Banerjee, SB Paruthy - Fungal metabolites, 2016 - ndl.ethernet.edu.et
Emerging viewpoints from contemporary research on terrestrial fungal metabolites provides
an insight into their valuable insidious biological activity including cancer therapeutics …
an insight into their valuable insidious biological activity including cancer therapeutics …
Enhancement of in vivo Antitumor Activity of a Novel Antimitotic 1‐Phenylpropenone Derivative, AM‐132, by Tumor Necrosis Factor‐cc or Interleukin‐6
Y Tatsumi, H Arioka, S Ikeda… - Japanese journal of …, 2001 - Wiley Online Library
TK5048 and its derivatives, AM‐132, AM‐138, and AM‐97, are recently developed
antimitotic (AM) compounds. These 1‐phenylpropenone derivatives induce cell cycle arrest …
antimitotic (AM) compounds. These 1‐phenylpropenone derivatives induce cell cycle arrest …